You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer

Article metrics

Article menu
XML
Basic tumor immunology
Original research
Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer

 

Online download statistics by month:

Online download statistics by month: July 2021 to January 2026

AbstractFullPdf
Jul 2021515111
Aug 2021796796328
Sep 2021372372151
Oct 2021392392136
Nov 2021271271148
Dec 202117417973
Jan 202215016278
Feb 202214815178
Mar 202210110454
Apr 202218118668
May 202214615473
Jun 2022129134104
Jul 202215115586
Aug 202215215870
Sep 2022168172104
Oct 202215315974
Nov 202212212246
Dec 202215715859
Jan 2023717251
Feb 202313213368
Mar 2023959549
Apr 2023919142
May 202311111577
Jun 2023849056
Jul 2023818767
Aug 2023717336
Sep 2023818542
Oct 2023898945
Nov 2023727233
Dec 2023757541
Jan 2024737443
Feb 2024626341
Mar 2024606084
Apr 2024757562
May 2024797934
Jun 2024707037
Jul 20248081154
Aug 2024474525
Sep 2024525538
Oct 20248082173
Nov 2024979845
Dec 202412312530
Jan 202510010352
Feb 202520020044
Mar 202510410552
Apr 202511611678
May 2025899071
Jun 2025727447
Jul 2025110
Jan 2026110
Total644865503458